| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |